One mechanism that could explain thrombocytosis in many tumors could be tumor-derived interleukin-6 (IL-6), which stimulates thrombopoietin (TPO) production in the liver, thereby promoting megakaryopoiesis and thrombocytosis [104]. This evidence concerns the gene IL6 and neoplasm.